GLP-1 Receptor Agonist Market Forecast, Trend Analysis & Opportunity Assessment 2020-2030

Aug 2020| FMI596A| Future Markets Insights

Report Highlights

GLP-1 Receptor Agonist Market: Global Industry Analysis 2015-2019 & Opportunity Assessment 2020-2030

A recent market study published by Future Market Insights (FMI) on the GLP-1 Receptor Agonist Market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the market, growth prospects of the market are obtained with utmost precision.

The report features unique and salient factors that may make a huge impact on the development of the GLP-1 Receptor Agonist Market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the market in the years to come. The report provides detailed information about the current and future growth prospects of the market in the most comprehensive way for better understanding of readers.

Key Segments of GLP-1 Receptor Agonist Market

FMI’s study on the market offers information divided into four important segments— Drug Class, Route of Administration, Application, and Region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

Exenatide
Liraglutide
Dulaglutide
Lixisenatide
Others
Route of Administration

Parenteral
Oral
Distribution Channel

Hospitals
Clinics
Ambulatory Surgical Centres
Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Chapter 1 – Executive Summary

The report commences with the executive summary of the GLP-1 Receptor Agonist Market report, which includes the snapshot of key findings and statistics. It also includes the market value (US$ million) estimates of the leading segments of the market and the key trends impacting the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and product definition of the GLP-1 Receptor Agonist Market in this chapter, which will help them understand basics of GLP – 1 Receptor Agonists.

Chapter 3 – Key Market Trends

This section highlights the key trends impacting the market, which will help readers understand the current trends and their impact on market growth.

Chapter 4 – Key Success Factors

This chapter explains the key macroeconomic factors that are expected to influence the growth of the market during the forecast period. It also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the market, which include the drivers, restraints, and opportunities.

This chapter is expected to enable readers understand the factors that are propelling the growth of the market, as well as those likely to hamper the growth. The opportunity analysis for the GLP-1 Receptor Agonist market will help readers understand the market opportunities, based on which they can plan their strategies.

In addition, this section provides the current and expected impact of Covid-19 on the market.

Chapter 5 – Global GLP-1 Receptor Agonist Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

This section explains the global market value analysis and forecast for the market during the forecast period along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 6 – Market Background

This chapter gives information about COVID-19 crisis impact analysis that comprises current COVID-19 statistics and probable future impact, impact on GDP of individual key countries, segment wise impact, quarter-wise forecast, and projected recovery quarter. In addition, it includes drivers and restraints of the market. Plus, there are macroeconomic factors and various opportunities listed for the GLP-1 Receptor Agonist Market.

Chapter 7 – Global GLP-1 Receptor Agonist Market Analysis (2015-2019) and Forecast (2020-2030), By Drug Class

Based on drug class, the market is segmented into Exenatide, Liraglutide, Dulaglutide, Lixisenatide, and Others. In this chapter, readers can find a detailed analysis of the market by different classes of drugs regarding GLP-1 Agonists and their growth over the forecast period.

Chapter 8 – Global GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast, 2020-2030, By Route of Administration

Based on route of administration, the market spans parenteral and oral. In this chapter, readers can find information on market attractiveness based on route of administration.

Chapter 9 – Global GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast, 2020-2030, By Distribution Channel

Based on distribution channel, the market comprises Hospitals, Clinics, and Ambulatory Surgical Centres. In this chapter, readers can find information on market attractiveness based on application.

Chapter 10 – Global GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030, By Region

This chapter explains how the market will grow across various regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

Chapter 11 – North America GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030

This chapter includes a detailed analysis of North America’s GLP-1 Receptor Agonist Market along with the country-wise assessment including the U.S. and Canada.

Chapter 12 – Latin America GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030

This chapter includes the growth prospects of the GLP-1 Receptor Agonist Market in Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America’s GLP-1 Receptor Agonist Market during 2020-2030.

Chapter 13 –Europe GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030

Important growth prospects of the GLP-1 Receptor Agonist Market based on product type, form, source, application in the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and Rest of Europe are included in this chapter.

Chapter 14 – South Asia GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030

India, Indonesia, Malaysia, Thailand, and the rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia’s GLP-1 Receptor Agonist Market. In this chapter, readers can find thorough information about the growth parameters of the South Asia’s GLP-1 Receptor Agonist Market during 2030.

Chapter 15 – East Asia GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030

Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia’s GLP-1 Receptor Agonist Market are included in this chapter. It also includes the growth prospects of the market in leading East Asian countries such as China, Japan, and South Korea.

Chapter 16 – Oceania GLP-1 Receptor Agonist Market Analysis 2014–2018 and Forecast 2020–2030

This chapter consists of important parameters that have a huge impact on the growth of the market in Oceania, based on market segmentation, during the forecast period. It also provides an overview of the drivers, restraints, and trends in the Oceania’s GLP-1 Receptor Agonist Market.

Chapter 17 – MEA GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030

This chapter provides information on how the market will grow in the major countries in GCC Countries, South Africa, Northern Africa, Turkey, and Rest of MEA during 2020-2030.

Chapter 18 – Key and Emerging Countries GLP-1 Receptor Agonist Market Analysis 2015-2019 and Forecast 2020-2030

This chapter provides information about the way the market will grow in the in the emerging economies as well as the key players in the forecast period (2020-2030).

Chapter 19 – Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis, and company share analysis along with sales footprint analysis of key player operating in GLP-1 Receptor Agonist Market.

Chapter 20 – Competitive Analysis

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the GLP-1 Receptor Agonist Market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the market report include Sanofi, Eli Lilly, AstraZeneca, and Novo Nordisk.

Chapter 21 – Assumptions and Acronyms Used

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 22 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information.

  • Table 1 : Global GLP-1 Receptor Market Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 2 : Global GLP-1 Receptor Market Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 3 : Global GLP-1 Receptor Market Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Table 4 : Global GLP-1 Receptor Market Analysis 2015-2019 and Forecast 2020–2030, By Region
  • Table 5 : North America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
  • Table 6 : North America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 7 : North America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 8 : North America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Table 9 : Latin America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
  • Table 10 : Latin America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 11 : Latin America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 12 : Latin America GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Table 13 : Europe GLP-1 Receptor Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
  • Table 14 : Europe GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 15 : Europe GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 16 : Europe GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Table 17 : South Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
  • Table 18 : South Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 19 : South Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 20 : South Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Table 21 : East Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
  • Table 22 : East Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 23 : East Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 24 : East Asia GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Table 25 : Oceania GLP-1 Receptor Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
  • Table 26 : Oceania GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 27 : Oceania GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 28 : Oceania GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Table 29 : Middle East and Africa GLP-1 Receptor Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
  • Table 30 : Middle East and Africa GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Drug Class
  • Table 31 : Middle East and Africa GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Route of Administration
  • Table 32 : Middle East and Africa GLP-1 Receptor Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
  • Figure 1 : Global GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 2 : Global GLP-1 Receptor Market Forecast & Y-o-Y Growth, 2020–2030
  • Figure 3 : Global GLP-1 Receptor Market Absolute $ Opportunity (US$ Mn) Analysis, 2019–2030
  • Figure 4 : Global GLP-1 Receptor Market Y-o-Y Growth (%) Analysis, 2019–2030
  • Figure 5 : Global GLP-1 Receptor Market Value Share (%) Analysis 2020 & 2030, By Drug Class
  • Figure 6 : Global GLP-1 Receptor Market Y-o-Y Growth (%) Analysis 2019-2030, By Drug Class
  • Figure 7 : Global GLP-1 Receptor Market Attractiveness Analysis 2020–2030, By Drug Class
  • Figure 8 : Global GLP-1 Receptor Market Value Share (%) Analysis 2020 & 2030, By Route of Administration
  • Figure 9 : Global GLP-1 Receptor Market Y-o-Y Growth (%) Analysis 2019-2030, By Route of Administration
  • Figure 10 : Global GLP-1 Receptor Market Attractiveness Analysis 2020–2030, By Route of Administration
  • Figure 11 : Global GLP-1 Receptor Market Value Share (%) Analysis 2020 & 2030, By Distribution Channel
  • Figure 12 : Global GLP-1 Receptor Market Y-o-Y Growth (%) Analysis 2019-2030, By Distribution Channel
  • Figure 13 : Global GLP-1 Receptor Market Attractiveness Analysis 2020–2030, By Distribution Channel
  • Figure 14 : Global GLP-1 Receptor Market Value Share (%) Analysis 2020 & 2030, By Region
  • Figure 15 : Global GLP-1 Receptor Market Y-o-Y Growth (%) Analysis 2019-2030, By Region
  • Figure 16 : Global GLP-1 Receptor Market Attractiveness Analysis 2020–2030, By Region
  • Figure 17 : North America GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 18 : North America GLP-1 Receptor Market Forecast & Y-o-Y growth, 2020–2030
  • Figure 19 : North America GLP-1 Receptor Market Attractiveness Analysis, By Drug Class
  • Figure 20 : North America GLP-1 Receptor Market Attractiveness Analysis, By Route of Administration
  • Figure 21 : North America GLP-1 Receptor Market Attractiveness Analysis, By Distribution Channel
  • Figure 22 : North America GLP-1 Receptor Market Attractiveness Analysis, By Country
  • Figure 23 : Latin America GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 24 : Latin America GLP-1 Receptor Market Forecast & Y-o-Y growth, 2020–2030
  • Figure 25 : Latin America GLP-1 Receptor Market Attractiveness Analysis, By Drug Class
  • Figure 26 : Latin America GLP-1 Receptor Market Attractiveness Analysis, By Route of Administration
  • Figure 27 : Latin America GLP-1 Receptor Market Attractiveness Analysis, By Distribution Channel
  • Figure 28 : Latin America GLP-1 Receptor Market Attractiveness Analysis, By Country
  • Figure 29 : Europe GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 30 : Europe GLP-1 Receptor Market Forecast & Y-o-Y growth, 2020–2030
  • Figure 31 : Europe GLP-1 Receptor Market Attractiveness Analysis, By Drug Class
  • Figure 32 : Europe GLP-1 Receptor Market Attractiveness Analysis, By Route of Administration
  • Figure 33 : Europe GLP-1 Receptor Market Attractiveness Analysis, By Distribution Channel
  • Figure 34 : Europe GLP-1 Receptor Market Attractiveness Analysis, By Country
  • Figure 35 : South Asia GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 36 : South Asia GLP-1 Receptor Market Forecast & Y-o-Y growth, 2020–2030
  • Figure 37 : South Asia GLP-1 Receptor Market Attractiveness Analysis, By Drug Class
  • Figure 38 : South Asia GLP-1 Receptor Market Attractiveness Analysis, By Route of Administration
  • Figure 39 : South Asia GLP-1 Receptor Market Attractiveness Analysis, By Distribution Channel
  • Figure 40 : South Asia GLP-1 Receptor Market Attractiveness Analysis, By Country
  • Figure 41 : East Asia GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 42 : East Asia GLP-1 Receptor Market Forecast & Y-o-Y growth, 2020–2030
  • Figure 43 : East Asia GLP-1 Receptor Market Attractiveness Analysis, By Drug Class
  • Figure 44 : East Asia GLP-1 Receptor Market Attractiveness Analysis, By Route of Administration
  • Figure 45 : East Asia GLP-1 Receptor Market Attractiveness Analysis, By Distribution Channel
  • Figure 46 : East Asia GLP-1 Receptor Market Attractiveness Analysis, By Country
  • Figure 47 : Oceania GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 48 : Oceania GLP-1 Receptor Market Forecast & Y-o-Y growth, 2020–2030
  • Figure 49 : Oceania GLP-1 Receptor Market Attractiveness Analysis, By Drug Class
  • Figure 50 : Oceania GLP-1 Receptor Market Attractiveness Analysis, By Route of Administration
  • Figure 51 : Oceania GLP-1 Receptor Market Attractiveness Analysis, By Distribution Channel
  • Figure 52 : Oceania GLP-1 Receptor Market Attractiveness Analysis, By Country
  • Figure 53 : Middle East and Africa GLP-1 Receptor Market Value Analysis, 2015–2019
  • Figure 54 : Middle East and Africa GLP-1 Receptor Market Forecast & Y-o-Y growth, 2020–2030
  • Figure 55 : Middle East and Africa GLP-1 Receptor Market Attractiveness Analysis, By Drug Class
  • Figure 56 : Middle East and Africa GLP-1 Receptor Market Attractiveness Analysis, By Route of Administration
  • Figure 57 : Middle East and Africa GLP-1 Receptor Market Attractiveness Analysis, By Distribution Channel
  • Figure 58 : Middle East and Africa GLP-1 Receptor Market Attractiveness Analysis, By Country
  • Figure 59 : U.S. GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 60 : U.S. GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 61 : U.S. GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 62 : Canada GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 63 : Canada GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 64 : Canada GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 65 : Mexico GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 66 : Mexico GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 67 : Mexico GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 68 : Brazil GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 69 : Brazil GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 70 : Brazil GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 71 : U.K. GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 72 : U.K. GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 73 : U.K. GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 74 : Germany GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 75 : Germany GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 76 : Germany GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 77 : France GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 78 : France GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 79 : France GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 80 : Italy GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 81 : Italy GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 82 : Italy GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 83 : Russia GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 84 : Russia GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 85 : Russia GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 86 : China GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 87 : China GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 88 : China GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 89 : Japan GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 90 : Japan GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 91 : Japan GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 92 : South Korea GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 93 : South Korea GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 94 : South Korea GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 95 : India GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 96 : India GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 97 : India GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 98 : Australia GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 99 : Australia GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 100 : Australia GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 101 : New Zealand GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 102 : New Zealand GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 103 : New Zealand GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 104 : GCC Countries GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 105 : GCC Countries GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 106 : GCC Countries GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 107 : Turkey GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 108 : Turkey GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 109 : Turkey GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E
  • Figure 110 : South Africa GLP-1 Receptor Market Share Analysis (%), 2020E & 2030F
  • Figure 111 : South Africa GLP-1 Receptor Market Share Analysis (%), By Drug Class, 2020E
  • Figure 112 : South Africa GLP-1 Receptor Market Share Analysis (%), By Route of Administration, 2020E

Future Market Insights is the premier provider of market intelligence and consulting services, serving client in over 160 countries. FMI is headquartered in London, the global financial capital and has delivery centers in the U.S. and India. FMI's research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure that our clients prepare for the evolving needs of their customers. FMI's team of over 200 research analysts provides market intelligence at global, regional, and country levels. Our analysts are committed to provide independent insights, relying on our cognitive training modules, which conditions them to look at data objectively and unbiasedly. Others you can use from the file Allen just shared when those will be made live.

Future Markets Insights
Price: $5000

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS